Treating critically ill patients with probiotics: Beneficial or dangerous?

by Jacobi Christoph A, Schulz Christian, Malfertheiner Peter
Published 2011-02-01

Implications of growth factor alterations in the treatment of pancreatic cancer

by Malfertheiner Peter, Nitsche Barbara, Juhász Márk, Ebert Matthias PA
Published 2003-01-01

A proposal for a new clinical classification of chronic pancreatitis

by Friess Helmut, Martignoni Marc E, Büchler Markus W, Malfertheiner Peter
Published 2009-12-01

Serological assessment of gastric mucosal atrophy in gastric cancer

by Bornschein Jan, Selgrad Michael, Wex Thomas, Kuester Doerthe, Malfertheiner Peter
Published 2012-01-01

GERD assessment including pH metry predicts a high response rate to PPI standard therapy

by Kandulski Arne, Peitz Ulrich, Mönkemüller Klaus, Neumann Helmut, Weigt Jochen, Malfertheiner Peter
Published 2013-01-01

Mucosal Progranulin expression is induced by <it>H. pylori</it>, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression

by Treiber Gerhard, Schindele Daniel, Schönberg Cornelius, Kuester Doerthe, Wex Thomas, Malfertheiner Peter
Published 2011-05-01

A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy

by Fill Malfertheiner Sara, Malfertheiner Maximilian V, Kropf Siegfried, Costa Serban-Dan, Malfertheiner Peter
Published 2012-09-01

Role of tight junction proteins in gastroesophageal reflux disease

by Mönkemüller Klaus, Wex Thomas, Kuester Doerthe, Fry Lucia C, Kandulski Arne, Kropf Siegfried, Roessner Albert, Malfertheiner Peter
Published 2012-09-01

Lack of association between gene polymorphisms of <it>Angiotensin converting enzyme</it>, <it>Nod-like receptor 1</it>, <it>Toll-like receptor 4, FAS/FASL </it>and the presence of...

by Kupcinskas Juozas, Wex Thomas, Bornschein Jan, Selgrad Michael, Leja Marcis, Juozaityte Elona, Kiudelis Gediminas, Jonaitis Laimas, Malfertheiner Peter
Published 2011-08-01

Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients...

by Bayerdörffer Ekkehard, Labenz Joachim, Madisch Ahmed, Malfertheiner Peter, Kulich Károly R, Miehlke Stephan, Carlsson Jonas, Wiklund Ingela K
Published 2003-10-01

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

by Schneider-Stock Regine, Röcken Christoph, Ebert Matthias PA, Csepregi Antal, Hoffmann Juliane, Schulz Hans-Ulrich, Roessner Albert, Malfertheiner Peter
Published 2010-06-01

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed <it>Helicobacter pylori </it>eradication

by Zaterka Schlioma, Malfertheiner Peter, Filho Moraes Joaquim PP, Rodriguez Tomás, Barbuti Ricardo C, Silva Fernando M, Eisig Jaime N
Published 2009-05-01

Quorum sensing in the probiotic bacterium <it>Escherichia coli</it> Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in...

by Jacobi Christoph A, Grundler Stefanie, Hsieh Chih-Jen, Frick Julia Stefanie, Adam Patrick, Lamprecht Georg, Autenrieth Ingo B, Gregor Michael, Malfertheiner Peter
Published 2012-08-01

Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease

by Bogdanos Dimitrios P, Roggenbuck Dirk, Reinhold Dirk, Wex Thomas, Pavlidis Polychronis, von Arnim Ulrike, Malfertheiner Peter, Forbes Alastair, Conrad Karsten, Laass Martin W
Published 2012-08-01

L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial

by Kraft Matthias, Kraft Kathleen, Gärtner Simone, Mayerle Julia, Simon Peter, Weber Eckhard, Schütte Kerstin, Stieler Jens, Koula-Jenik Heide, Holzhauer Peter, Gröber Uwe, Engel Georg, Müller Cornelia, Feng You-Shan, Aghdassi Ali, Nitsche Claudia, Malfertheiner Peter, Patrzyk Maciej, Kohlmann Thomas, Lerch Markus M
Published 2012-07-01

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.

by Xu, Yiwang, Miremadi, Ahmad, Link, Alexander, Malfertheiner, Peter, Fitzgerald, Rebecca C, Bornschein, Jan
Published 2019

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

by Alunni-Fabbroni, Marianna, Rönsch, Kerstin, Huber, Thomas, Cyran, Clemens C., Seidensticker, Max, Mayerle, Julia, Pech, Maciej, Basu, Bristi, Verslype, Chris, Benckert, Julia, Malfertheiner, Peter, Ricke, Jens
Published 2020

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.

by Alunni-Fabbroni, Marianna, Rönsch, Kerstin, Huber, Thomas, Cyran, Clemens C, Seidensticker, Max, Mayerle, Julia, Pech, Maciej, Basu, Bristi, Verslype, Chris, Benckert, Julia, Malfertheiner, Peter, Ricke, Jens
Published 2019

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib.

by Öcal, Osman, Schinner, Regina, Schütte, Kerstin, de Toni, Enrico N, Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Gebauer, Bernhard, Zech, Christoph J, Sengel, Christian, Bargellini, Irene, Gasbarrini, Antonio, Sangro, Bruno, Pech, Maciej, Malfertheiner, Peter, Ricke, Jens, Seidensticker, Max, SORAMIC study group
Published 2022

Dynamics in Circulating y -55Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial

by Schütte, Kerstin, Kupčinskas, Juozas, Morkunas, Egidijus, Öcal, Osman, Schinner, Regina, Seidensticker, Max, De Toni, Enrico N, Ben Khaled, Najib, Pech, Maciej, Palmer, Daniel, Berg, Thomas, Sengel, Christian, Basu, Bristi, Valle, Juan W, Benckert, Julia, Gasbarrini, Antonio, Sangro, Bruno, Malfertheiner, Peter, Ricke, Jens
Published 2022